Physician

Sunit Ratilal Patel, M.D.

According to 2025 Medicare claims, Sunit Patel, M.D. (NPI: 1437184777) practices pulmonary disease in the Merced, CA market, with the plurality of this provider's patient population coming from Merced, CA. This provider's primary affiliated billing organization is SUNIT R PATEL MD A PROFESSIONAL CORPORATION (NPI: 1245403500; TIN: 412115545) and primary practice location at 95340-0982.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,096 traditional Medicare patients, billed 6,367 HCPCS/CPT codes, and received $615,645 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,506 prescription claims across 700 beneficiaries totaling $1,715,972 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 17,980 claims. Open Payments data shows 98 records totaling $2,357. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $669,025 to $1,715,972. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $552,355 to $733,590.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,053	7,342	$674,705
2016	2,073	7,179	$689,679
2017	2,120	7,096	$680,272
2018	2,095	7,389	$706,127
2019	2,250	7,599	$724,680
2020	2,112	6,460	$542,642
2021	1,958	5,803	$553,880
2022	1,913	6,204	$560,749
2023	2,002	6,853	$624,267
2024	2,096	6,367	$615,645

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	475	2,948	$669,025
2016	396	2,457	$680,472
2017	418	2,591	$773,026
2018	476	2,974	$926,175
2019	536	2,981	$871,589
2020	819	4,432	$1,848,385
2021	795	4,959	$2,704,984
2022	619	3,012	$2,276,378
2023	622	3,164	$2,276,998
2024	700	3,506	$1,715,972

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	3,829	8,347	$586,191
2016	4,036	9,140	$412,286
2017	4,656	10,155	$367,901
2018	6,251	14,067	$481,651
2019	7,702	17,790	$647,701
2020	8,258	20,694	$1,167,229
2021	7,602	19,274	$1,076,314
2022	6,789	17,595	$998,128
2023	6,917	18,482	$1,100,000
2024	6,850	17,980	$917,912

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	416	416	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,599	2,882	$95
94726	Test to determine lung volumes using sensors	419	426	$44
94729	Test to examine how well the lungs exchange gases	436	443	$43
94060	Test to measure expiratory airflow and volume changes before and after medication administration	339	342	$31

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	700	24,734	$509,117
Ofev	Nintedanib Esylate	23	690	$295,826
Adempas	Riociguat	11	330	$138,118
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	133	5,160	$104,260
Spiriva Respimat	Tiotropium Bromide	110	4,560	$76,324

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	23	162	$126,419
A7031	Face mask interface, replacement for full face mask, each	N	454	1,035	$87,116
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	156	1,202	$83,092
A7030	Full face mask used with positive airway pressure device, each	N	465	990	$81,125
A7032	Cushion for use on nasal mask interface, replacement only, each	N	289	609	$54,197

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	98	$2,357	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sunit Ratilal Patel, M.D.?

Tedicare shows public-source Medicare data for Sunit Ratilal Patel, M.D. (NPI 1437184777), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sunit Ratilal Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sunit Ratilal Patel, M.D.?

Sunit Ratilal Patel, M.D. is linked to SUNIT R PATEL MD A PROFESSIONAL CORPORATION (billing NPI 1245403500) in the available physician profile data.

Does Sunit Ratilal Patel, M.D. have Open Payments data?

Sunit Ratilal Patel, M.D. has 98 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.